CL2015000357A1 - Compuestos derivados de 2-fenil-3-(fenil/piridin/tiofen)-2,4,5,6-tetrahidrociclopenta[c]pirazoles, bloqueadores del canal de calcio tipo n; composicion farmaceutica; y un metodo para tratar el dolor inflamatorio o neuropatico - Google Patents

Compuestos derivados de 2-fenil-3-(fenil/piridin/tiofen)-2,4,5,6-tetrahidrociclopenta[c]pirazoles, bloqueadores del canal de calcio tipo n; composicion farmaceutica; y un metodo para tratar el dolor inflamatorio o neuropatico

Info

Publication number
CL2015000357A1
CL2015000357A1 CL2015000357A CL2015000357A CL2015000357A1 CL 2015000357 A1 CL2015000357 A1 CL 2015000357A1 CL 2015000357 A CL2015000357 A CL 2015000357A CL 2015000357 A CL2015000357 A CL 2015000357A CL 2015000357 A1 CL2015000357 A1 CL 2015000357A1
Authority
CL
Chile
Prior art keywords
phenyl
tetrahydrocyclopenta
pyrazoles
pyridin
thiophene
Prior art date
Application number
CL2015000357A
Other languages
English (en)
Inventor
Michael P Winters
Zhihua Sui
Christopher Flores
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49036654&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2015000357(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of CL2015000357A1 publication Critical patent/CL2015000357A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10Spiro-condensed systems
    • C07D491/113Spiro-condensed systems with two or more oxygen atoms as ring hetero atoms in the oxygen-containing ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CL2015000357A 2012-08-16 2015-02-16 Compuestos derivados de 2-fenil-3-(fenil/piridin/tiofen)-2,4,5,6-tetrahidrociclopenta[c]pirazoles, bloqueadores del canal de calcio tipo n; composicion farmaceutica; y un metodo para tratar el dolor inflamatorio o neuropatico CL2015000357A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201261683775P 2012-08-16 2012-08-16

Publications (1)

Publication Number Publication Date
CL2015000357A1 true CL2015000357A1 (es) 2015-06-12

Family

ID=49036654

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2015000357A CL2015000357A1 (es) 2012-08-16 2015-02-16 Compuestos derivados de 2-fenil-3-(fenil/piridin/tiofen)-2,4,5,6-tetrahidrociclopenta[c]pirazoles, bloqueadores del canal de calcio tipo n; composicion farmaceutica; y un metodo para tratar el dolor inflamatorio o neuropatico

Country Status (21)

Country Link
US (1) US8853418B2 (es)
EP (1) EP2885279A1 (es)
JP (1) JP6262231B2 (es)
KR (1) KR20150042270A (es)
CN (1) CN105189464B (es)
AU (1) AU2013302469B2 (es)
BR (1) BR112015003328A2 (es)
CA (1) CA2882042A1 (es)
CL (1) CL2015000357A1 (es)
CR (1) CR20150068A (es)
EA (1) EA201590382A1 (es)
EC (1) ECSP15009830A (es)
HK (1) HK1217690A1 (es)
IL (1) IL237189A0 (es)
IN (1) IN2015DN01237A (es)
MX (1) MX2015002037A (es)
PE (1) PE20151137A1 (es)
PH (1) PH12015500314A1 (es)
SG (1) SG11201501140RA (es)
WO (1) WO2014028801A1 (es)
ZA (1) ZA201501746B (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014028800A1 (en) 2012-08-16 2014-02-20 Janssen Pharmaceutica Nv Substituted pyrazoles as n-type calcium channel blockers
EP2957559A1 (en) * 2014-06-18 2015-12-23 L'Universite de Strasbourg Iminosydnone derivatives for conjugation and release of compounds of interest

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1287174B1 (it) * 1996-11-15 1998-08-04 Angelini Ricerche Spa Diaril-ciclometilenpirazoli farmacologicamente attivi,procedimento per prepararli e composizioni farmaceutiche che li contengono
JP2001220390A (ja) * 2000-02-09 2001-08-14 Yamanouchi Pharmaceut Co Ltd 縮合ピラゾール誘導体
AU2005221138A1 (en) * 2004-03-08 2005-09-22 Wyeth Ion channel modulators
CN1938281A (zh) * 2004-03-08 2007-03-28 惠氏公司 离子通道调节剂
EP1963275A2 (en) * 2005-11-09 2008-09-03 Abbott Laboratories P2x7 receptor antagonists and uses thereof

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9974775B2 (en) 2013-08-16 2018-05-22 Janssen Pharmaceutica Nv Substituted imidazoles as N-type calcium channel blockers

Also Published As

Publication number Publication date
EP2885279A1 (en) 2015-06-24
JP6262231B2 (ja) 2018-01-17
CA2882042A1 (en) 2014-02-20
US20140051660A1 (en) 2014-02-20
KR20150042270A (ko) 2015-04-20
JP2015524851A (ja) 2015-08-27
PH12015500314A1 (en) 2015-03-30
ZA201501746B (en) 2017-08-30
HK1217690A1 (zh) 2017-01-20
BR112015003328A2 (pt) 2017-07-04
AU2013302469A1 (en) 2015-02-26
CR20150068A (es) 2015-04-30
CN105189464A (zh) 2015-12-23
PE20151137A1 (es) 2015-08-07
US8853418B2 (en) 2014-10-07
IN2015DN01237A (es) 2015-06-26
WO2014028801A1 (en) 2014-02-20
CN105189464B (zh) 2017-12-12
SG11201501140RA (en) 2015-04-29
IL237189A0 (en) 2015-04-30
ECSP15009830A (es) 2015-12-31
EA201590382A1 (ru) 2015-08-31
AU2013302469B2 (en) 2017-08-24
MX2015002037A (es) 2016-01-22

Similar Documents

Publication Publication Date Title
CL2015000360A1 (es) Compuestos derivados de pirazoles sustituidos, bloqueadores del canal de calcio tipo n; composicion farmaceutica que los comprende; metodo para tratar el dolor inflamatorio y el dolor neuropatico.
CL2015000358A1 (es) Compuestos derivados de pirazoles sustitutos,utiles como bloqueadores del canal de calcio tipo n; composicion farmaceutica y su proceso de elaboracion; y un metodo para tratar el dolor inflamatorio o neuropatico.
MA44050A (fr) Nouveaux composés
HK1220412A1 (zh) 改良的細胞外基質組合物的製作方法
CL2015000816A1 (es) Compuestos derivados de piridinonas; composicion farmaceutica; un metodo para tratar una condicion fibrotica.
DK3068392T3 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme
GB2544342B (en) Compositions for application to wounds
DK2968071T3 (da) Enhed til oral levering af terapeutiske forbindelser
DK2768479T3 (da) Hjælpestoffer til nikotin-indeholdende terapeutiske sammensætninger
CL2013001722A1 (es) Compuestos derivados de amidas azociclicas fungicidas; metodo para controlar enfermedades en plantas.
EA201290644A1 (ru) Блокаторы натриевых потенциал-зависимых каналов
ZA201507876B (en) 3-(4-isobutyl-2-methylphenyl) propanal as perfume ingredient
DK4066819T3 (da) Små liposomer til levering af RNA, der koder for immunogen
PL2688405T3 (pl) Kompozycje zawierające polimerowe, jonowe związki zawierające grupy imidazoliowe
GB2532158B (en) Novel cement composition for lost circulation application
DK3646881T3 (da) Sammensætning til kontrolleret ovariestimulering
DK2787982T3 (da) Sammensætning til tarmpræparat
DK2957282T3 (en) Oral antiseptic composition for treating oral mucositis
DK2734212T3 (da) Sammensætninger omfattende diclofenac til behandling af postoperativ smerte
BR112014000306A2 (pt) uma nova composição terapêutica contendo apomorfina como ingrediente ativo
BR112014032001A2 (pt) composto, composição fungicida e método para controlar doenças de plantas
ZA201403268B (en) Novel compositions, preparation thereof and use thereof for production of cast polyamides
BR112014032077A2 (pt) composto, composição fungicida e método para controlar doenças de plantas
BR112014009775A2 (pt) composição, método, semente e composto de fórmula 1
FR2977491B1 (fr) Composition cosmetique comprenant un melange de miels